2006-2007 Colorado Bioscience Magazine Unveiled At Colorado BioScience Association 2006 Annual Membership Meeting
Colorado BioScience Association released new 76-page issue of Bioscience Colorado Magazine at the 2006 Annual Membership Meeting. In addition, seven new appointments were made to the Board of Directors, along with eight reappointments; 2006 Corporate Sponsors were introduced; and Brandon Shaffer, Colorado State Senator District 17, was presented the national Biotechnology Industry Organization Legislator of the Year Award.
Denver, CO, April 18, 2006 --(PR.com)-- The 2006-2007 issue of Bioscience Colorado Magazine was released to members at the Colorado BioScience Association (CBSA) 2006 Annual Membership Meeting held today in Boulder at the University of Colorado. The announcement is made by Denise Brown, CBSA executive director, who says this publication, now expanded to 76 pages, is an important tool used to inform the world about the bioscience industry in Colorado.
“Our magazine has attracted potential partners to our member companies, generated increased interest from investors, and the helped to inform Coloradans about the industry and its contributions, of which they can be proud,” Brown explains. “This is the third issue of the magazine that CBSA has published.”
The new issue includes features on major worldwide disease threats and what Colorado companies are doing to tackle them.
Here is a sampling (you can link to articles of interest at the pdf http://www.cobioscience.com/2006biosciencemagazine.pdf):
SMALL COMPANIES FIGHTING SMALL BUGS - Page 10
Infectious diseases kill 15 million people a year, and are the leading cause of death in developing nations. But until recently, U.S. pharmaceutical companies found little profit in vaccines, antibiotics and related drugs. Vaccines are costly to produce but have low profit margins. Sometimes the actual number of doses used is small, while the potential for pandemic is large. Often the afflicted live in countries too poor to buy drugs, or in spots too remote to store refrigerated products. Colorado companies fighting infectious diseases: InViragen, Replidyne, Heska,, MicroPhage, Aktiv-Dry, Roche Colorado, Mycologics, RxKinetix and Windom Peak Pharmaceuticals.
21st CENTURY MEDICINE: PULMONOLOGY/IMMUNOLOGY - Page 22
It began as a medical myth: tuberculosis patients in the 1890s believed Denver’s abundant sunshine and dry air would cure them. Of course it wasn’t true, but as patients flocked to the area, hospitals arose that now rank amongst the world’s premiere respiratory centers. In recent years, National Jewish has attracted $40 million to $50 million in grants annually. A quarter of its funds come from industry, and licensing deals have grown each year. Colorado companies with pulmonology/immunology focus: Taligen Therapeutics, Accelr8, Sentry Biosciences, Amgen, Colorado include BioStar and Ferraris Respiratory.
COLORADO COMPANIES TACKLE CANCER - Page 35
A cure for cancer is the Holy Grail of modern medicine. But so far, despite more than a half century of research and a handful of incremental successes, researchers have yet to make a giant breakthrough. The scope of the problem is clear: cancer is the No. 2 killer of Americans, second only to cardiac disease, taking 500,000 lives a year. And the incidence of cancer is rising in developing nations as people live longer, making cancer a truly global disease. More than a half dozen Colorado firms at work on cancer treatments. Colorado companies working in the Oncology segment: Tapestry, Array BioPharma, GlobeImmune, Allos Therapeutics, RxKinetix, Valleylab, Pharmion, Amgen, OSI Pharmaceuticals, Cytologic, SomaLogic, Thinc Pharmaceuticals, Newellink USA, Radiological Imaging Technology, Cell-Point and CeMines.
TAKING COLORADO’S PULSE - Page 34
In 2005 publicly traded Myogen announced encouraging clinical trial results for its two most advanced candidates, ambrisentan and darusentan. The drugs treat pulmonary arterial hypertension and resistant hypertension, respectively. Myogen is among a handful of firms in Colorado working on treatments for heart diseases, broadly speaking. Some – such as Spectranetics – have long marketed products. Others are in the early stages of venture funding. Colorado companies developing and selling products used in cardiac care: Myogen, Spectranetics, PR Pharmaceuticals, CardioOptics, Cardiac Access LLC, Braun BioSystems, Genesee BioMedical, ARCA Discovery and COBE Cardiovascular.
COLORADO’S ACTIVE LIFESTYLE LEADS TO ORTHOPEDICS CLUSTER - Page 36
Colorado is home to some of the world’s best snow skiing, backpacking and marathon races. And so youngsters and baby boomers alike flock to the state in order to race down winter slopes and clamber to alpine meadows. But at the end of a weekend’s fun, hospitals and sports medicine clinics see the consequences: torn cartilage, worn joints, herniated disks. So perhaps it’s no surprise that Colorado is also home to a handful of companies working to improve common orthopedic procedures such as knee realignment, hip replacement and spinal fusion surgeries. These businesses are poised to tap into the tremendous growth in orthopedic surgeries due to the aging U.S. population. Colorado's Orthopedic companies: C5 Medical Werks, CoorsTek, Medtronic Navigation, iBalance Medical, CeraPedics, TMJ Implants, Medispec, AcuNetx and Synthes.
In other action at the meeting, CBSA’s 2006 corporate sponsors were announced to the membership. In addition, seven new appointments were made to the board of directors, along with eight reappointments.
Brandon Shaffer, State Senator District 17, was presented the national Biotechnology Industry Organization (BIO) Legislator of the Year Award at the event. Senator Shaffer was presented the award by Eric Bergeson, vice president of site operations for Amgen Colorado (http://www.amgen.com), who co-sponsored Senator Shaffer’s nomination for the national award along with CBSA. Amgen, a long-time supporter of CBSA has become a Gold Sponsor in 2006.
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. Complete information is available at http://www.bio.org.
David Allen, the University of Colorado Associate VP for Technology Transfer, gave a presentation on “Ingredients for Technology Transfer Success” and assessed the technology transfer situation at CU in light of these factors. Allen has been CU's chief technology transfer office for four years. Previous to CU he held similar positions at The Ohio State University, Columbus, and Ohio University, Athens.
About Colorado BioScience Association
Colorado BioScience Association is a not-for-profit corporation providing services and support for Colorado’s growing biosciences industry. Colorado is carrying out an aggressive plan to grow the state’s bioscience industry into one of the country’s premier bioscience clusters. CBSA currently enjoys the support of more than 300 member organizations representing both bioscience companies and companies providing key services to the bioscience industry and research institutions in Colorado. The association’s main office is located in the Advance Colorado Center, 1625 Broadway, Suite 950, in Denver, plus satellite offices are maintained in the Fitzsimons Bioscience Park and at the Fort Collins Technology Incubator. A Colorado Springs satellite office is planned for the future. You can learn more about CBSA at the website http://www.cobioscience.com
Contacts:
Denise Brown, Executive Director, Colorado BioScience Association, http://www.cobioscience.com, 303.592.4073 or 303.915.9762, E-mail: dbrown@cobioscience.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations, http://www.absolutelypr.com, 303.984.9801 or 303.669.3558, E-mail: maggie@absolutelypr.com
###
“Our magazine has attracted potential partners to our member companies, generated increased interest from investors, and the helped to inform Coloradans about the industry and its contributions, of which they can be proud,” Brown explains. “This is the third issue of the magazine that CBSA has published.”
The new issue includes features on major worldwide disease threats and what Colorado companies are doing to tackle them.
Here is a sampling (you can link to articles of interest at the pdf http://www.cobioscience.com/2006biosciencemagazine.pdf):
SMALL COMPANIES FIGHTING SMALL BUGS - Page 10
Infectious diseases kill 15 million people a year, and are the leading cause of death in developing nations. But until recently, U.S. pharmaceutical companies found little profit in vaccines, antibiotics and related drugs. Vaccines are costly to produce but have low profit margins. Sometimes the actual number of doses used is small, while the potential for pandemic is large. Often the afflicted live in countries too poor to buy drugs, or in spots too remote to store refrigerated products. Colorado companies fighting infectious diseases: InViragen, Replidyne, Heska,, MicroPhage, Aktiv-Dry, Roche Colorado, Mycologics, RxKinetix and Windom Peak Pharmaceuticals.
21st CENTURY MEDICINE: PULMONOLOGY/IMMUNOLOGY - Page 22
It began as a medical myth: tuberculosis patients in the 1890s believed Denver’s abundant sunshine and dry air would cure them. Of course it wasn’t true, but as patients flocked to the area, hospitals arose that now rank amongst the world’s premiere respiratory centers. In recent years, National Jewish has attracted $40 million to $50 million in grants annually. A quarter of its funds come from industry, and licensing deals have grown each year. Colorado companies with pulmonology/immunology focus: Taligen Therapeutics, Accelr8, Sentry Biosciences, Amgen, Colorado include BioStar and Ferraris Respiratory.
COLORADO COMPANIES TACKLE CANCER - Page 35
A cure for cancer is the Holy Grail of modern medicine. But so far, despite more than a half century of research and a handful of incremental successes, researchers have yet to make a giant breakthrough. The scope of the problem is clear: cancer is the No. 2 killer of Americans, second only to cardiac disease, taking 500,000 lives a year. And the incidence of cancer is rising in developing nations as people live longer, making cancer a truly global disease. More than a half dozen Colorado firms at work on cancer treatments. Colorado companies working in the Oncology segment: Tapestry, Array BioPharma, GlobeImmune, Allos Therapeutics, RxKinetix, Valleylab, Pharmion, Amgen, OSI Pharmaceuticals, Cytologic, SomaLogic, Thinc Pharmaceuticals, Newellink USA, Radiological Imaging Technology, Cell-Point and CeMines.
TAKING COLORADO’S PULSE - Page 34
In 2005 publicly traded Myogen announced encouraging clinical trial results for its two most advanced candidates, ambrisentan and darusentan. The drugs treat pulmonary arterial hypertension and resistant hypertension, respectively. Myogen is among a handful of firms in Colorado working on treatments for heart diseases, broadly speaking. Some – such as Spectranetics – have long marketed products. Others are in the early stages of venture funding. Colorado companies developing and selling products used in cardiac care: Myogen, Spectranetics, PR Pharmaceuticals, CardioOptics, Cardiac Access LLC, Braun BioSystems, Genesee BioMedical, ARCA Discovery and COBE Cardiovascular.
COLORADO’S ACTIVE LIFESTYLE LEADS TO ORTHOPEDICS CLUSTER - Page 36
Colorado is home to some of the world’s best snow skiing, backpacking and marathon races. And so youngsters and baby boomers alike flock to the state in order to race down winter slopes and clamber to alpine meadows. But at the end of a weekend’s fun, hospitals and sports medicine clinics see the consequences: torn cartilage, worn joints, herniated disks. So perhaps it’s no surprise that Colorado is also home to a handful of companies working to improve common orthopedic procedures such as knee realignment, hip replacement and spinal fusion surgeries. These businesses are poised to tap into the tremendous growth in orthopedic surgeries due to the aging U.S. population. Colorado's Orthopedic companies: C5 Medical Werks, CoorsTek, Medtronic Navigation, iBalance Medical, CeraPedics, TMJ Implants, Medispec, AcuNetx and Synthes.
In other action at the meeting, CBSA’s 2006 corporate sponsors were announced to the membership. In addition, seven new appointments were made to the board of directors, along with eight reappointments.
Brandon Shaffer, State Senator District 17, was presented the national Biotechnology Industry Organization (BIO) Legislator of the Year Award at the event. Senator Shaffer was presented the award by Eric Bergeson, vice president of site operations for Amgen Colorado (http://www.amgen.com), who co-sponsored Senator Shaffer’s nomination for the national award along with CBSA. Amgen, a long-time supporter of CBSA has become a Gold Sponsor in 2006.
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. Complete information is available at http://www.bio.org.
David Allen, the University of Colorado Associate VP for Technology Transfer, gave a presentation on “Ingredients for Technology Transfer Success” and assessed the technology transfer situation at CU in light of these factors. Allen has been CU's chief technology transfer office for four years. Previous to CU he held similar positions at The Ohio State University, Columbus, and Ohio University, Athens.
About Colorado BioScience Association
Colorado BioScience Association is a not-for-profit corporation providing services and support for Colorado’s growing biosciences industry. Colorado is carrying out an aggressive plan to grow the state’s bioscience industry into one of the country’s premier bioscience clusters. CBSA currently enjoys the support of more than 300 member organizations representing both bioscience companies and companies providing key services to the bioscience industry and research institutions in Colorado. The association’s main office is located in the Advance Colorado Center, 1625 Broadway, Suite 950, in Denver, plus satellite offices are maintained in the Fitzsimons Bioscience Park and at the Fort Collins Technology Incubator. A Colorado Springs satellite office is planned for the future. You can learn more about CBSA at the website http://www.cobioscience.com
Contacts:
Denise Brown, Executive Director, Colorado BioScience Association, http://www.cobioscience.com, 303.592.4073 or 303.915.9762, E-mail: dbrown@cobioscience.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations, http://www.absolutelypr.com, 303.984.9801 or 303.669.3558, E-mail: maggie@absolutelypr.com
###
Contact
Colorado BioScience Association
Maggie Holben
303-984-9801
http://www.cobioscience.com
Maggie Holben
303-984-9801
http://www.cobioscience.com
Contact
Categories